-
NYSE to Commence Delisting Proceedings Against Vicarious Surgical Inc. (RBOT)
-
Vicarious Surgical completes animal testing for robotic surgery system
-
Vicarious Surgical partners with software firm to cut development costs
-
NYSE to delist Vicarious Surgical warrants due to low price levels
-
Vicarious Surgical Inc. (RBOT) files $100M mixed shelf
-
Vicarious Surgical lowers 2025 cash burn guidance to $45 million
-
Vicarious Surgical Inc. (RBOT) files for 2.3M share offering by selling stockholders
-
Vicarious Surgical Inc. (RBOT) Misses Q3 EPS by 177c
-
Vicarious Surgical inc. (RBOT) PT Lowered to $7 at Piper Sandler
-
Vicarious Surgical Inc. (RBOT) Misses Q2 EPS by 223c
-
Vicarious Surgical Inc. (RBOT) Electes Fuad Ahmad and Joseph Doherty to its Board
-
Piper Sandler Highlights Top Medtech Picks and Catalyst-Rich Names
-
GlucoTrack (GCTK) elects Victoria Carr-Brendel to Board
-
Vicarious Surgical Inc. (RBOT) Misses Q1 EPS by 258c
-
Vicarious Surgical Inc. (RBOT) Announces President Transition to Board Member Role
-
Vicarious Surgical inc. (RBOT) PT Lowered to $8.50 at Piper Sandler
-
BTIG Reiterates Neutral Rating on Vicarious Surgical inc. (RBOT)
-
Vicarious Surgical Inc. (RBOT) Appoints Sarah Romano as CFO
-
Vicarious Surgical Inc. (RBOT) Announces Planned Retirement of Chief Operating Officer
-
Vicarious Surgical (RBOT) Announces Departure of Chief Financial Officer
-
Vicarious Surgical inc. (RBOT) PT Lowered to $10.50 at Piper Sandler
-
Vicarious Surgical inc. (RBOT) PT Raised to $10 at TD Cowen
-
Vicarious Surgical inc. (RBOT) PT Lowered to $12 at Piper Sandler
-
Vicarious Surgical (RBOT) Announces New Hospital System Partnership with LSU Health New Orleans
-
Vicarious Surgical Inc. (RBOT) Announces 1:30 Reverse Share Split

